Transaction DateRecipientSharesTypePriceValue
19th November 2020Jeffrey E. Eberwein7,866Open or private purchase$2.46$19,350.36
18th November 2020Jeffrey E. Eberwein12,134Open or private purchase$2.52$30,577.68
9th November 2020David J. Noble1,916Exercise of derivative$0.00
27th October 2020Dimitrios Angelis12,387Grant/award etc.$2.22$27,499.14
16th August 2020Jeffrey E. Eberwein1,250Exercise of derivative$0.00
16th August 2020John W. Sayward1,250Exercise of derivative$0.00
16th August 2020Mitchell I Quain2,250Exercise of derivative$0.00
16th August 2020Michael A. Cunnion1,250Exercise of derivative$0.00
28th July 2020Dimitrios Angelis20,522Grant/award etc.$1.34$27,499.48
22nd July 2020Jeffrey E. Eberwein114,624Other acquisition or disposition$0.00
Digirad Corporation
Digirad Corporation logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.

Digirad Corp. engages in the provision of mobile healthcare solutions. It operates through the following segments: Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. The Mobile Healthcare segment provides contract diagnostic imaging, including computerized tomography, magnetic resonance imaging, positron emission tomography and healthcare expertise to hospitals. The Diagnostic imaging segment develops solid-state gamma cameras, imaging systems and camera maintenance contracts.

Ticker: DRAD
Sector: Healthcare
Industry: Medical Devices
SEC Central Index Key (CIK): 707388
Employees: 452
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Cash at Carrying Value: $9 M (400%)
Inventory, Net: $8 M (0%)
Other Assets, Current: $1 M (-20%)
Assets, Current: $33 M (11%)
Property, Plant and Equipment, Net: $19 M (0%)
Other Assets, Noncurrent: $997 Th (-14%)
Assets: $89 M (-1%)
Long-term Debt, Current Maturities: $4 M (0%)
Accounts Payable, Current: $6 M (-34%)
Liabilities, Current: $24 M (-13%)
Long-term Debt, Excluding Current Maturities: $19 M (12%)
Other Liabilities, Noncurrent: $1 M (-28%)
Liabilities: $48 M (-4%)
Common Stock, Shares, Issued: $5 M (128%)
Retained Earnings (Accumulated Deficit): $123 M (0%)
Treasury Stock, Value: $57 Th (0%)
Treasury Stock, Shares: $3 M (0%)
Stockholders' Equity (Parent): $21 M (0%)
Liabilities and Equity: $89 M (-1%)
Cost of Revenue: $18 M (-57%)
Gross Margin: $4 M (0%)
Sales and Marketing: $5 M (-56%)
Operating Income/Loss: $2 M (1%)
Other Income, net: $289 Th (1011%)
Provision for income taxes: $50 Th (-40%)